BridgeMD
New treatment option for Stroke
Official title B2AD-Risk AFDAS Evolution of Burden of AF
ClinicalTrials.gov ID: NCT06589700
What this study is testing
- What it's testing
- Each year, 7.8 million people worldwide experience an ischemic stroke, often caused by atrial fibrillation (AF). AF is a major contributor to severe, disabling, and deadly strokes.
- Time commitment: about 24 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients with cortical or subcortical, cryptogenic or non-cryptogenic acute ischemic stroke
- Any of the following types of AF:
- Paroxysmal AF known before stroke onset (KAF).
- Paroxysmal AF found on an admission or Emergency Department ECG (ECG-AFDAS)
- Paroxysmal AF found on 14-day Holter monitoring (PCM-AFDAS)
You likely can't join if
- Patients not willing to consent
- Permanent or persistent AF
- Allergy to iodinated contrast agents
The study team makes the final eligibility decision.
Where it's taking place
- London, Ontario, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.